Document Detail


Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention.
MedLine Citation:
PMID:  19138316     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Hyperparathyroidism (HPT) during pregnancy is rare but poses a significant danger to mother and baby yet the incidence of pregnancy loss and its relationship to the degree of calcium elevation is not known. DESIGN: A retrospective patient series from a single practice examined the past and current obstetrical histories of pregnant patients with primary HPT. RESULTS: Over a period of 6-years, 32 women age ranging from 19 to 40 years had a total of 77 pregnancies while having elevated serum calcium levels because of primary HPT (incidence 0.7% of all women with primary HPT). Fifteen patients underwent parathyroidectomy during the second trimester resulting in an uneventful delivery of a healthy infant between 36 and 40 weeks gestation. There were no maternal or infant complications at surgery or during the subsequent delivery. Thirty of the remaining 62 pregnancies (48%) were lost, a rate that is 3.5-fold higher than expected (P < 0.05). In those who did not have the HPT addressed after the first miscarriage, one-third lost one or more additional pregnancies. Pregnancy loss occurred typically in the late first or early second trimester, with second trimester losses (30%) being sixfold higher than expected (P < 0.01) and over 4 weeks later than typical (P < 0.05). Foetal loss was seen at all levels of elevated maternal calcium but most were above 11.4 mg/dl (2.85 mmol/l). The rate of foetal loss increased directly with increasing maternal serum calcium levels (R = 0.972). CONCLUSIONS: HPT during pregnancy is under recognized and is associated with a 3.5-fold increase in miscarriage rates. Pregnancy loss often occurs in the second trimester and is associated with multiple miscarriages when not addressed. Pregnancy loss is more common as calcium levels exceed 11.4 mg/dl (2.85 mmol/l), but can be seen at all elevated calcium levels. Emphasis is placed on earlier recognition and surgical cure before becoming pregnant, however, once pregnant, surgery should be offered early in the second trimester for those with calcium levels above 11.4 mg/dl.
Authors:
James Norman; Douglas Politz; Laura Politz
Related Documents :
2146876 - Second trimester maternal serum pregnancy specific beta-1 glycoprotein (sp-1) levels in...
17957376 - First trimester serum inhibin a in normal pregnant women.
10417506 - Serum concentrations of tramadol enantiomers during patient-controlled analgesia.
22604746 - Pathological cases of the month: case 1.
18515596 - Late outgrowth endothelial progenitor cells in patients with age-related macular degene...
7292936 - Induction of twin-calving by non-surgical embryo transfer: a field trial.
Publication Detail:
Type:  Journal Article     Date:  2008-12-05
Journal Detail:
Title:  Clinical endocrinology     Volume:  71     ISSN:  1365-2265     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-20     Completed Date:  2009-10-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  England    
Other Details:
Languages:  eng     Pagination:  104-9     Citation Subset:  IM    
Affiliation:
Norman Parathyroid Clinic, Tampa, Florida 33613, USA. jnorman@parathyroid.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Spontaneous / blood*,  etiology*
Adult
Calcium / blood*
Female
Follow-Up Studies
Humans
Hyperparathyroidism / blood,  complications*
Pregnancy
Retrospective Studies
Young Adult
Chemical
Reg. No./Substance:
7440-70-2/Calcium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as first-line investigation for the...
Next Document:  Bone protective therapy in the young patient with fractures and chronic disease: what drug(s) should...